IHH Healthcare registered a net profit of $573m (RM$1.9b) in year-to-date (YTD) 2024, dropping 13% year-on-year (YoY).
The decrease was due to a high base last year, which recorded one-off gains of $263m (RM873.0m) from the sale of International Medical University (IMU). Excluding exceptional items, net profit grew by 35%.
Revenue and EBITDA for the period posted double-digit growth of 13% and 12%, respectively, reaching $5.3b (RM17.7b) and $1.2b (RM4.0b). The growth was driven by sustained increases in patient volumes and revenue intensity across all markets.
For Q3 2024, IHH Healthcare achieved a 73% occupancy rate, with 232,071 patient admissions across 12,220 operational beds.
In the next five years, the group intends to add approximately 4,000 new beds under its “Align-Challenge-Empower” (ACE) framework.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.